HSP90B2P and neoplasm: In breast cancer, several reports [16,17,18] have shown that a complex interplay between tumor and stromal cells create a pro-angiogenic environment in which the HSP mediated by HIF members is the key regulator, as shown by loss-of-function experiments [19].